This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Jan 1;27(1):160; author reply 160.

doi: 10.1200/JCO.2008.19.3839. Epub 2008 Dec 1.

Blood-based early detection of malignant mesothelioma

Eun-Kee Park, Paul S Thomas, Jenette Creaney, Anthony R Johnson, Bruce W Robinson, Deborah H Yates

PMID: 19047302
DOI: 10.1200/JCO.2008.19.3839

Comment

Blood-based early detection of malignant mesothelioma

Eun-Kee Park et al. J Clin Oncol. 2009.

. 2009 Jan 1;27(1):160; author reply 160.

doi: 10.1200/JCO.2008.19.3839. Epub 2008 Dec 1.

Authors

Eun-Kee Park, Paul S Thomas, Jenette Creaney, Anthony R Johnson, Bruce W Robinson, Deborah H Yates

PMID: 19047302
DOI: 10.1200/JCO.2008.19.3839

No abstract available

PubMed Disclaimer

Comment on

Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
Simon GR, Verschraegen CF, Jänne PA, Langer CJ, Dowlati A, Gadgeel SM, Kelly K, Kalemkerian GP, Traynor AM, Peng G, Gill J, Obasaju CK, Kindler HL. Simon GR, et al. J Clin Oncol. 2008 Jul 20;26(21):3567-72. doi: 10.1200/JCO.2007.15.2868. J Clin Oncol. 2008. PMID: 18640937 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.